High-flow Nasal Cannula Oxygenation Decrease Hypoxia in Sedated Gastrointestinal Endoscopes in Obesity: a Randomized Multicenter Clinical Trial
Status: Recruiting
Location: See all (3) locations...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
Hypoxia is the most common adverse event during gastrointestinal endoscopes sedated with propofol and sufentanil, especially in obese people. In the present study, high-flow nasal cannula oxygenation will be utilized in order to reduce the incidence of hypoxia among obesity.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 70
Healthy Volunteers: f
View:
• patients undergoing gastrointestinal endoscopes
• age≥18 years old and ≤70 years old
• patients or family members signed informed consent form
• ASA classification I-II
• BMI≥ 28kg/m²
Locations
Other Locations
China
Renji hospital, School of Medicine, Shanghai Jiaotong University
RECRUITING
Shanghai
Shanghai Oriental Hospital
RECRUITING
Shanghai
Shanghai Tongji Hospital
RECRUITING
Shanghai
Contact Information
Primary
Diansan Su, Dr.
diansansu@yahoo.com
+862168383702
Time Frame
Start Date: 2021-05-06
Estimated Completion Date: 2024-01
Participants
Target number of participants: 1000
Treatments
Active_comparator: Control group
Oxygen(up to 6L/min) supplied with a regular nasal catheter
Experimental: High-flow nasal cannula group
Oxygen(up to 60L/min) supplied with high-flow nasal cannula
Related Therapeutic Areas
Sponsors
Collaborators: Shanghai Tongji Hospital, Tongji University School of Medicine, Shanghai Oriental Hospital, Tongji University School of Medicine
Leads: RenJi Hospital